| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
phenotype | 0.600 | None | 1.000 | 1 | 0 | 1999 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
phenotype | 0.510 | None | 1.000 | 1 | 0 | 2002 | 2008 | ||||||||
|
angiotensinogen | 0.367 | 0.923 | 5.0E-08 |
|
phenotype | 0.510 | None | 1.000 | 1 | 0 | 2002 | 2015 | ||||||||
|
decorin | 0.457 | 0.808 | 0.31 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2003 | 2011 | ||||||||
|
cellular communication network factor 2 | 0.399 | 0.846 | 5.0E-04 |
|
phenotype | 0.260 | None | 1.000 | 1 | 0 | 2003 | 2008 | ||||||||
|
interleukin 13 | 0.386 | 0.846 | 1.4E-02 |
|
phenotype | 0.240 | None | 1.000 | 1 | 0 | 2003 | 2008 | ||||||||
|
ras homolog family member A | 0.502 | 0.808 | 0.60 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2005 | 2006 | ||||||||
|
bradykinin receptor B1 | 0.619 | 0.731 | 4.7E-03 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2004 | 2009 | ||||||||
|
intercellular adhesion molecule 1 | 0.364 | 0.962 | 3.5E-02 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2008 | 2012 | ||||||||
|
angiotensin II receptor type 1 | 0.423 | 0.846 | 5.3E-04 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 1997 | 2011 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2003 | 2008 | ||||||||
|
lumican | 0.543 | 0.731 | 7.7E-02 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 1992 | 2003 | ||||||||
|
histone deacetylase 3 | 0.511 | 0.731 | 0.57 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
calreticulin | 0.413 | 0.923 | 0.89 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
collagen type XVIII alpha 1 chain | 0.449 | 0.808 | 1.7E-10 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
suppressor of cytokine signaling 3 | 0.434 | 0.808 | 0.75 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
cyclin dependent kinase inhibitor 1B | 0.409 | 0.769 | 0.62 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
C-C motif chemokine ligand 11 | 0.473 | 0.885 | 1.0E-02 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
peroxisome proliferator activated receptor gamma | 0.358 | 0.885 | 2.9E-02 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
angiotensin II receptor type 2 | 0.496 | 0.808 | 8.2E-03 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
cytochrome P450 family 11 subfamily B member 1 | 0.563 | 0.615 | 8.2E-07 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
histone deacetylase 4 | 0.484 | 0.885 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2014 | 2014 |